PIPELINE  
   
PLATFORM THERAPY

Dendritic Cell/Tumor Cell Fusion Vaccine + IL(Interleukin)-12
Combination therapy of fusion cell vaccine with IL-12

CyTIX developed a combination therapy by adding IL(Interleukin)-12 as an adjuvant to a fusion cell vaccine.

Clinical Research Data in Malignant Brain Tumor (Addition)therapies for many types of cancerous tumors.
 

© Copyright 2017 CyTIX Inc. All rights reserved.